Kairos Pharma, LTD. (KAPA)

CIK 1962011 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kairos Pharma, LTD..

Recent SEC filings

FiledFormAccession number
Aug 21, 20268-K0001493152-26-039695
Aug 12, 202610-Q0001493152-26-037355
Jul 22, 20268-K0001493152-26-034185
Jul 15, 20268-K0001493152-26-033289
Jun 30, 20268-K0001493152-26-031328
Jun 4, 20268-K0001493152-26-027200
May 26, 2026DEFA14A0001493152-26-025287
May 22, 2026ARS0001493152-26-025021
May 22, 2026DEF 14A0001493152-26-025020
May 18, 20268-K0001493152-26-024082
May 13, 202610-Q0001493152-26-022796
May 11, 2026PRE 14A0001493152-26-022194
Apr 1, 2026424B30001493152-26-014692
Apr 1, 2026424B30001493152-26-014691
Mar 31, 202610-K0001493152-26-014159
Mar 2, 20268-K0001493152-26-008435
Feb 26, 20268-K0001493152-26-008116
Jan 23, 2026EFFECT9999999995-26-000284
Jan 13, 2026S-30001493152-26-001909
Dec 30, 202540001493152-25-029601
Dec 23, 202540001493152-25-028895
Nov 26, 202540001493152-25-025205
Nov 26, 202540001493152-25-025203
Nov 26, 202540001493152-25-025224
Nov 26, 202540001493152-25-025197